Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 297 results for "lupin"

Lupin gaining traction, Buy for a target of Rs 1640: Sacch...

Sacchitanand Uttekar of Motilal Oswal Financial Services has given a buy on Lupin Ltd. at Rs 1512.75 as trading volumes surged to 19313 over previous day. Analyst gave the target of Rs 1640 and a stop loss of Rs 1420 . The analyst gave 1-3 days for ... Economic Times, 14 hours ago

347 images for lupin, 1 week ago
Farming Ahead, 16 hours ago
News, 1 week ago
Financial Express, 1 week ago, 1 week ago
Financial Express, 5 days ago
Wanganui Chronicle, 1 week ago
PharmaVOICE, 2 weeks ago, 2 weeks ago
Domain-B, 1 week ago

Chart Check: Lupin, NMDC, Vedanta, Godrej Consumer Products

Here are a few trading ideas from Chandan Taparia of Anand Rathi for trade today: BUY LUPIN: The stock snapped the losses made in previous week and reclaimed its Rs 1500 zones. It crossed and closed above its hurdle of Rs 1508 levels and is ...
 Smart Investor4 days ago Chart Check: Lupin, TVS Motors, Asian Paints, Bank of India  Smart Investor1 week ago

Lupin in pact with Boehringer Ingelheim to market diabetic drug

As per the agreement, Lupin will market and sell empagliflozin under a separate brand name Gibtulio which will be promoted by Lupin's specialty field force Hyderabad: Lupin Ltd, India's third largest drugmaker, Thursday said it formed an alliance ...
 Livemint.com1 week ago Boehringer Ingelheim, Lupin in agreement for type II diabetes  Express Pharma1 week ago Boehringer Ingelheim India and Lupin enter agreement to market diabetes drug  Economic Times1 week ago Lupin and Boehringer Ingelheim ink co-marketing pact for diabetes drug empagliflozin  Business Standard1 week ago

Resistance for Nifty at 8775; Lupin, UPL bullish plays: Gaba

Nifty has support at 8550 and resistance at 8775 while Bank Nifty has support at 19200 and resistance at 19800, says Prakash Gaba of
 Money Control4 days ago Support for Nifty at 8600-8550; HDFC bullish play: Prakash Gaba  Money Control2 months ago
India Infoline

Lupin, MonoSol Rx sign pact for multiple pediatric products

PharmFilm technology to be used for pediatric applications Drug firm Lupin and US-based specialty pharmaceutical firm MonoSol Rx have signed a licensing agreement for multiple pediatric products. Lupin Pharma, the company's US subsidiary, and ...
 Express Pharma1 week ago Lupin to use MonoSol technology for developing paediatric products  Business Standard2 weeks ago Lupin licenses MonoSol's dissolvable film delivery platform  FierceBiotech2 weeks ago Lupin and Monosol Rx enters into a strategic licensing agreement for multiple pediatric-focused products  India Infoline2 weeks ago

Lupin Q2 PAT seen down 28.6% to Rs 630 cr: Centrum

Net Sales are expected to decrease by 3.6 percent Q-o-Q (up 28.9 percent Y-o-Y) to Rs 4280 crore, according to Centrum.
 Money Control5 days ago Lupin extends downtrend; shares slide nearly 4%  Business Standard2 months ago Lupin hits over 1-month low; results fail to cheer market  Sify2 months ago Lupin shares dip 5%; mcap falls by Rs 3,823 cr post Q1 results  Business Standard2 months ago
Times of India

Boehringer, Lupin to co-market diabetes drug

Mumbai: MNC drug firm Boehringer Ingelheim and domestic company Lupin announced an alliance to co-market anti-diabetes drug, Empagliflozin, a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor in India. This is the second partnership between ...
 Times of India1 week ago Boehringer Ingelheim, Lupin tie up to co-market anti-diabetes drug  Times of India1 week ago BRIC Diabetes Drugs Market Expected to Have a Worldwide Growth 2015-2021 - PMR  Digital Journal1 week ago

Lupin, BC Partners shortlisted for Bayer's $1.1 bn dermatology business

India's fourth-largest drug maker by sales, Lupin Ltd, and private equity firm BC Partners have been shortlisted as prospective buyers for German chemicals and drugmaker Bayer AG's dermatology business worth around €1 billion ($1.1 billion). ...
 Domain-B1 week ago Bayer's medical skin creams draw suitors Lupin, BC Partners -sources  Reuters Africa1 week ago Bayer eyes $1B sale of medical skin cream business  MassDevice1 week ago

Lupin enters into a strategic alliance with Boehringer Ingelheim

India, Oct. 14 -- Lupin and Boehringer Ingelheim have entered into a strategic alliance to co-market Empagliflozin, a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor in India. Boehringer Ingelheim and Lupin had earlier signed a partnership ...
 HT Syndication1 week ago Boehringer Ingelheim, Lupin announce strategic co-marketing agreement  Money Control1 week ago
Financial Express

Technical Calls: Buy Ashok Leyland, Reliance Industries, Lupin

Lupin has been in a consistent decline since couple of months from 2115 levels. After attempting to find a bottom at 1395, the stock may show a trend reversal in coming days. This week, the levels of 8,790 and 8,850 will act as stiff resistance ...
 Financial Express2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - lupin
Get updated on latest news & your favorite topics right in your inbox!
More     Less